starryeyes
Senior Member
- Messages
- 1,561
- Location
- Bay Area, California
How much does it cost to Delete the SPARK! pages and the Toolkit?
On top of CAA, it seems that CDC is in a "rebuilding" phase, or at least I hope. With a new leadership, I would have hopes that CAA and CDC could build on strength and work on common goals. We have yet to hear from CDC. Their website has not been updated, so I wonder what they are up to, if anything?
The only way the public can influence medical policy is to fund compelling and scientifically strong private research. The WPI is a great example of that. Their study initiated work at HHS.
I don't think having a special ME/CFS episode of House, or ER is going to influence doctors, researchers, or the powers that be. My best friend is a doctor, my brother in law is one too. They literally roll their eyes at these types of shows.
Consider that the SSA pays out in the neighborhood of $1.5 billion in disability payments for CFS, while we get less then $10 million yearly in federally funded research? It makes no sense. There's medical political bias, and I'm going to speculate that there's surely some nefarious lobbying by insurers going on too.
The only way to sort this out, again, is strong evidence based studies showing biological impairment in CFS, that's what doctors and researchers care about -- not television medical dramas!!
While I am horrified that Peter "CFS patients are the least deserving" White was quoted in the CAA literature, the research program actually has potential to influence how CFS is viewed medically. That's a much better use of funds than PR consultants.
It is medical recklessness that furthers misinformation in a crafty way by seemingly trying to "educate."
The project got underway, officially, in October of 2000 with thousands of dollars given to the CAA to help it along and make sure that the CAA fell within the federal's CDC misinformation arena.
Attending a session will enable the physician to learn some misinformation about CFS along with helping to fulfill the requirements of CMEs.
In addition, the CAA gets to exhibit the material at medical meetings by setting up educational booths where the misinformation can be spread further.
With additional funding, the CAA is now producing an educational video to spread this misinformation even further to physicians who do not have an opportunity to attend a local training session or have internet access.
An overview of CFS says the illness "is characterized by...multiple nonspecific symptoms."
No mention of swollen lymph nodes or low-grade fevers in the overview. They must be too specific.
What this committee was trying to accomplish was apparent to several of those on the committee. One, an infectious disease specialist from Harvard Medical School, said "Is the intention to create a new psychiatric classification?" He, along with other members of the committee, quit rather than sign on to the trivializing name.
While this "education project" goes on to state that "the nation's Surgeon General, Dr. David Satcher, has agreed that the term CFS is no longer appropriate," the CAA has been the one enduring blockade to seeing this accomplishment for years.
They state "It is unclear if CFS patients have abnormal cortisol
levels." In fact, the NIH tried to prove this was a mental illness by looking for high levels of cortisol. Instead, they found low or low-normal levels. So they refused to publish!
And one of these is that the prevalence of children. The NIH refused to fund Dr. Leonard Jason to go on to study this. But he still went on and did a study on kids and found that the rate was about half of that in adults but rather even in gender.
the CAA say "it is important to direct careful attention to family functioning to identify and address underlying family problems or psychopathology that may be contributing to symptoms." Not only has the invalid and cruel label of "Maunchausens-by-proxie" been unfairly put upon parents trying to get help for their sick children, but this document quite obviously gives support to this crime.
These physicians suggest so little testing that if this packet is for the purpose of making sure the patient never gets disability, it's reached its goal.
They even say "The presence of severe objective muscle weakness, neurological signs, or cardio-respiratory disease might indicate other conditions."
Lest anybody come away thinking CFS could probably be a serious illness, they again point out that "CFS is not terminal, but suicide is a choice that some persons make with CFS..."
Why do I blame the CAA for miseducating our doctors and for failing to change the name "CFS"? See below. We need to understand the history of the CME packet in order to understand why it's so dangerous to us.
Background to the history of the CAA's CME (Continuing Medical Education Credits):
http://www.ncf-net.org/forum/EducationProjectTreason.html
Excerpts:
How many more children are going to be removed from their homes and families because they are stricken with CFS?
How much does it cost to Delete the SPARK! pages and the Toolkit?
Originally Posted by Cort
Is GET still so crazy that it asks you to push through your symptoms and your crashes? If so then it should be banned. I had thought that GET was more like - slowly, very slowly increase your activity levels - so long as you don;t flare up. I thought it had evolved into something more like PACING actually.
<snip>
* The above is my underline
This is where I think advocacy can go off the rails. Why keep recommending GET if what we really mean is pacing? Stop making things more difficult than needed. Stop asking your audience to appreciate a nuanced (confused) version of a loaded recommendation. Simpler, not more complex!
To stimulate research aimed at the early detection, objective diagnosis and effective treatment of CFS through expanded public, private and commercial investment.
Before my ramble, I'll start with full disclosure about my personal stance about the CAA. I basically support the CAA (and donate what I can when I can) for 2 reasons.
....
In practice when you are dealing with someone on the ground, who has in their head that GET is the way to go, there is basically no reasoning with them. There is a power imbalance in the relationship between the patient and the medical people they deal with, so this is important to take into account also, and it is easy for the patient to seem uncooperative to medical people if you don't follow their recommendations.
We have found that the press is only interested when there is something new. XMRV is a case in point: that got the press interested because it was big and it was new. Coverage has fallen since then, with blips for the UK and Dutch studies. So new research findings, are the way to get the press attention (or scandal, or controversy, but you get my point).
J Affect Disord. 2009 May;115(1-2):280-6. Epub 2008 Oct 19.
Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome.
Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ.
King's College London, Institute of Psychiatry, Department of Psychological Medicine, De Crespigny Park, London SE5 8AF, UK.
BACKGROUND: There is evidence that patients with chronic fatigue syndrome (CFS) have mild hypocortisolism. One theory about the aetiology of this hypocortisolism is that it occurs late in the course of CFS via factors such as inactivity, sleep disturbance, chronic stress and deconditioning. We aimed to determine whether therapy aimed at reversing these factors--cognitive behavioural therapy for CFS--could increase cortisol output in CFS. METHODS: We measured diurnal salivary cortisol output between 0800 and 2000 h before and after 15 sessions (or 6 months) of CBT in 41 patients with CDC-defined CFS attending a specialist, tertiary outpatient clinic. RESULTS: There was a significant clinical response to CBT, and a significant rise in salivary cortisol output after CBT. LIMITATIONS: We were unable to control for the passage of time using a non-treated CFS group. CONCLUSIONS: Hypocortisolism in CFS is potentially reversible by CBT. Given previous suggestions that lowered cortisol may be a maintaining factor in CFS, CBT offers a potential way to address this.
Cognitive behaviour therapy for chronic fatigue syndrome in adults.
Price JR, Mitchell E, Tidy E, Hunot V.
Department of Psychiatry, University of Oxford, Warneford Hospital, Headington, Oxford, UK, OX3 7JX. jonathan.price@psych.ox.ac.uk
Comment in:
Evid Based Ment Health. 2009 Feb;12(1):16.
Update of:
Cochrane Database Syst Rev. 2000;(2):CD001027.
BACKGROUND: Chronic fatigue syndrome (CFS) is a common, debilitating and serious health problem. Cognitive behaviour therapy (CBT) may help to alleviate the symptoms of CFS. OBJECTIVES: To examine the effectiveness and acceptability of CBT for CFS, alone and in combination with other interventions, compared with usual care and other interventions. SEARCH STRATEGY: CCDANCTR-Studies and CCDANCTR-References were searched on 28/3/2008. We conducted supplementary searches of other bibliographic databases. We searched reference lists of retrieved articles and contacted trial authors and experts in the field for information on ongoing/completed trials. MAIN RESULTS: Fifteen studies (1043 CFS participants) were included in the review. When comparing CBT with usual care (six studies, 373 participants), the difference in fatigue mean scores at post-treatment was highly significant in favour of CBT (SMD -0.39, 95% CI -0.60 to -0.19), with 40% of CBT participants (four studies, 371 participants) showing clinical response in contrast with 26% in usual care (OR 0.47, 95% CI 0.29 to 0.76). Findings at follow-up were inconsistent. For CBT versus other psychological therapies, comprising relaxation, counselling and education/support (four studies, 313 participants), the difference in fatigue mean scores at post-treatment favoured CBT (SMD -0.43, 95% CI -0.65 to -0.20). Findings at follow-up were heterogeneous and inconsistent. Only two studies compared CBT against other interventions and one study compared CBT in combination with other interventions against usual care. AUTHORS' CONCLUSIONS: CBT is effective in reducing the symptoms of fatigue at post-treatment compared with usual care, and may be more effective in reducing fatigue symptoms compared with other psychological therapies. The evidence base at follow-up is limited to a small group of studies with inconsistent findings. There is a lack of evidence on the comparative effectiveness of CBT alone or in combination with other treatments, and further studies are required to inform the development of effective treatment programmes for people with CFS.
Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome.
de Lange FP, Koers A, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JW, Toni I.
F.C. Donders Centre for Cognitive Neuroimaging, Radboud University Nijmegen, Kapittelweg 29, 6500 HB Nijmegen, The Netherlands. florisdelange@gmail.com
Comment in:
Brain. 2009 Jun;132(Pt 6):e110; author reply e111.
Chronic fatigue syndrome (CFS) is a disabling disorder, characterized by persistent or relapsing fatigue. Recent studies have detected a decrease in cortical grey matter volume in patients with CFS, but it is unclear whether this cerebral atrophy constitutes a cause or a consequence of the disease. Cognitive behavioural therapy (CBT) is an effective behavioural intervention for CFS, which combines a rehabilitative approach of a graded increase in physical activity with a psychological approach that addresses thoughts and beliefs about CFS which may impair recovery. Here, we test the hypothesis that cerebral atrophy may be a reversible state that can ameliorate with successful CBT. We have quantified cerebral structural changes in 22 CFS patients that underwent CBT and 22 healthy control participants. At baseline, CFS patients had significantly lower grey matter volume than healthy control participants. CBT intervention led to a significant improvement in health status, physical activity and cognitive performance. Crucially, CFS patients showed a significant increase in grey matter volume, localized in the lateral prefrontal cortex. This change in cerebral volume was related to improvements in cognitive speed in the CFS patients.Our findings indicate that the cerebral atrophy associated with CFS is partially reversed after effective CBT. This result provides an example of macroscopic cortical plasticity in the adult human brain, demonstrating a surprisingly dynamic relation between behavioural state and cerebral anatomy. Furthermore, our results reveal a possible neurobiological substrate of psychotherapeutic treatment.
Br J Psychiatry. 2008 Mar;192(3):217-23.
Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial.
Stubhaug B, Lie SA, Ursin H, Eriksen HR.
Division of Psychiatry, Haukeland University Hospital, N-5021 Bergen, Norway. bjarte.stubhaug@helse-bergen.no
BACKGROUND: Single interventions in chronic fatigue syndrome have shown only limited effectiveness, with few studies of comprehensive treatment programmes. AIMS: To examine the effect of a comprehensive cognitive-behavioural treatment (CCBT) programme compared with placebo-controlled mirtazapine medication in patients with chronic fatigue, and to study the effect of combined medication and CCBT. METHOD: A three-armed randomised clinical trial of mirtazapine, placebo and a CCBT programme was conducted to investigate treatment effect in a patient group (n=72) with chronic fatigue referred to a specialist clinic. The CCBT programme was compared with mirtazapine or placebo therapy for 12 weeks, followed by 12 weeks treatment with a mixed crossover-combination design. Assessments were done at 12 weeks and 24 weeks. RESULTS: By 12 weeks the treatment effect was significantly better in the group initially receiving CCBT, as assessed with the Fatigue Scale (P=0.014) and the Clinical Global Impression Scale (P=0.001). By 24 weeks the treatment group initially receiving CCBT for 12 weeks followed by mirtazapine for 12 weeks showed significant improvement compared with the other treatment groups on the Fatigue Scale (P<0.001) and the Clinical Global Impression Scale (P=0.002). Secondary outcome measures showed overall improvement with no significant difference between treatment groups. CONCLUSIONS: Multimodal interventions may have positive treatment effects in chronic fatigue syndrome. Sequence of interventions seem to be of importance.
Efficacy of cognitive behavioral therapy for adolescents with chronic fatigue syndrome: long-term follow-up of a randomized, controlled trial.
Knoop H, Stulemeijer M, de Jong LW, Fiselier TJ, Bleijenberg G.
Expert Centre Chronic Fatigue, Radboud University, Nijmegen Medical Centre, Postbox 9011, 6525 EC Nijmegen, The Netherlands. j.knoop@nkcv.umcn.nl
OBJECTIVES: The purpose of this work was to assess the long-term outcome of adolescents with chronic fatigue syndrome who received cognitive behavioral therapy and to determine the predictive value of fatigue severity and physical impairments of the adolescent and the fatigue severity of the mother at baseline for the outcome of the treatment at follow-up. PATIENTS AND METHODS: Sixty-six adolescent patients with chronic fatigue syndrome who previously participated in a randomized, controlled trial that showed that cognitive behavioral therapy was more effective than a waiting-list condition in reducing fatigue and improving physical functioning were contacted for a follow-up assessment. Fifty participants of the follow-up study had received cognitive behavioral therapy for chronic fatigue syndrome (32 formed the cognitive behavioral therapy group in the original trial, and 18 patients received cognitive behavioral therapy after the waiting period). The remaining 16 patients had refused cognitive behavioral therapy after the waiting period. The main outcome measures were fatigue severity (Checklist Individual Strength), physical functioning (Short-Form General Health Survey), and school attendance. RESULTS: Data were complete for 61 patients at follow-up (cognitive behavioral therapy group: 47 patients; no-treatment group: 14 patients). The mean follow-up time was 2.1 years. There was no significant change in fatigue severity between posttreatment and follow-up in the cognitive behavioral therapy group. There was a significant further increase in physical functioning and school attendance (10% increase). The adolescents in the cognitive behavioral therapy group were significantly less fatigued and significantly less functionally impaired and had higher school attendance at follow-up than those in the no-treatment group. Fatigue severity of the mother was a significant predictor of treatment outcome. CONCLUSIONS: The positive effects of cognitive behavioral therapy in adolescents with chronic fatigue syndrome are sustained after cognitive behavioral therapy. Higher fatigue severity of the mother predicts lower treatment outcome in adolescent patients.
"While CBT is frequently prescribed as a coping strategy, it can also improve fatigue and activity levels. Optimally, CBT can help your patients better adapt to the impact of CFS and improve their quality of life."
"Some patients are resistant to this therapy because they mistakenly believe health practitioners who prescribe CBT believe CFS is purely a psychological illness."
"Educating patients about the role CBT can play in helping them learn to manage activity levels, stress and symptoms may help overcome this reluctance."
"CBT practitioners can lead individual patients to understand how their behavior is impacting the illness and set up activity and exercise programs that are therapeutic."
When you're in a CBT program, you will be expected to push through your crashes and do more than you really should and you will be expected to do some kind of exercise and to be increasing it as time goes on.
"CBT often involves the introduction of very slowly increased physical activity."
"Even people with extremely limited tolerance can be helped to gradually achieve increased strength and conditioning."